MX2022004052A - Composicion novedosa para el cuidado de la piel. - Google Patents

Composicion novedosa para el cuidado de la piel.

Info

Publication number
MX2022004052A
MX2022004052A MX2022004052A MX2022004052A MX2022004052A MX 2022004052 A MX2022004052 A MX 2022004052A MX 2022004052 A MX2022004052 A MX 2022004052A MX 2022004052 A MX2022004052 A MX 2022004052A MX 2022004052 A MX2022004052 A MX 2022004052A
Authority
MX
Mexico
Prior art keywords
skin care
care composition
acnes
skin
relates
Prior art date
Application number
MX2022004052A
Other languages
English (en)
Inventor
Peter Steidle
Daniel Richter
Jennifer Hüpeden
Bernhard Felten
Jane Djamil
Stefan Gallinat
Petra Schöndienst
Joern Hendrik Reuter
Heike Foelster
Tina Hamann
Willy Verheyen
De Lima João Pedro Quintão Reis Pereira
Bernhard Felix Pätzold
Original Assignee
S Biomedic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Biomedic filed Critical S Biomedic
Publication of MX2022004052A publication Critical patent/MX2022004052A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere en general al campo del cuidado de la piel. Más particularmente, la invención se refiere a una composición para el cuidado de la piel cosmética o terapéutica que comprende bacterias vivas de al menos una cepa de Cutibacterium acnes (C. acnes) en combinación con una carga que apoya específicamente su viabilidad durante el almacenamiento y/o su capacidad de replicación después de su aplicación en la piel. Preferentemente, la composición para el cuidado de la piel cosmética o terapéutica comprende bacterias de al menos una cepa de C. acnes seleccionada del grupo que consiste en D1, A5, C1, C3, H1, H2, H3, K1, K2, K4, K6, K8, K9, L1 y F4. La invención también proporciona un método para tratar o prevenir el acné mediante la aplicación de la composición para el cuidado de la piel de la invención en una zona de la piel que necesita tratamiento. La invención también se refiere al uso de una composición para el cuidado de la piel de la invención para tratar o prevenir el acné.
MX2022004052A 2019-10-03 2019-12-18 Composicion novedosa para el cuidado de la piel. MX2022004052A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19201255 2019-10-03
PCT/EP2019/085880 WO2021063529A1 (en) 2019-10-03 2019-12-18 Novel skin care composition

Publications (1)

Publication Number Publication Date
MX2022004052A true MX2022004052A (es) 2022-05-02

Family

ID=68137890

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004052A MX2022004052A (es) 2019-10-03 2019-12-18 Composicion novedosa para el cuidado de la piel.

Country Status (6)

Country Link
US (1) US20230038623A1 (es)
EP (1) EP4037769A1 (es)
CN (1) CN114929193A (es)
BR (1) BR112022006362A2 (es)
MX (1) MX2022004052A (es)
WO (1) WO2021063529A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10774305B2 (en) 2015-04-20 2020-09-15 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
ES2967029T3 (es) 2016-10-19 2024-04-25 S Biomedic Nv Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas
WO2023110886A1 (en) * 2021-12-17 2023-06-22 S-Biomedic A freeze-dried composition and preparation thereof
EP4197523A1 (en) * 2021-12-17 2023-06-21 DSM IP Assets B.V. A freeze-dried composition and preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743609B1 (en) 1997-12-23 2004-06-01 Arkion Life Sciences Llc Linoleate isomerase
US10774305B2 (en) 2015-04-20 2020-09-15 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
KR20180123475A (ko) * 2016-02-05 2018-11-16 더 리전츠 오브 더 유니버시티 오브 캘리포니아 피부 건강을 촉진하기 위한 조성물 및 방법
CA3021793A1 (en) * 2016-04-21 2017-10-26 Naked Biome, Inc. Compositions and methods for treatment of skin disorders
ES2967029T3 (es) * 2016-10-19 2024-04-25 S Biomedic Nv Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas
DE102016012651A1 (de) 2016-10-24 2018-04-26 Beiersdorf Ag Mehrkomponentenapplikator

Also Published As

Publication number Publication date
EP4037769A1 (en) 2022-08-10
CN114929193A (zh) 2022-08-19
WO2021063529A1 (en) 2021-04-08
US20230038623A1 (en) 2023-02-09
BR112022006362A2 (pt) 2022-06-28

Similar Documents

Publication Publication Date Title
MX2022004051A (es) Composicion novedosa para el cuidado de la piel.
MX2022004052A (es) Composicion novedosa para el cuidado de la piel.
MX2022004054A (es) Composicion novedosa para el cuidado de la piel.
MX2022004056A (es) Composicion novedosa para el cuidado de la piel.
MX2022004055A (es) Composicion novedosa para el cuidado de la piel.
PH12018502634A1 (en) Topical compositions of apremilast
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
MX2021016034A (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella.
MX2022000027A (es) Extracto de ca?amo para tratamiento del dolor, cancer y epilepsia en animales.
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
MX2020011817A (es) Metodos para tratar el linfoma.
MX2022004048A (es) Composicion novedosa para el cuidado de la piel.
MX2022006533A (es) Un esteroide c21-n-pirazolilo 19-nor c3,3-disustituido y metodos de uso del mismo.
MX2022004050A (es) Composicion novedosa para el cuidado de la piel.
CR20220329A (es) Anticuerpos anti–mertk y metodos de uso de los mismos
ZA202104166B (en) Sulcardine administration for treatment of acute atrial fibrillation
CR20210514A (es) USO DE REBOXETINA PARA EL TRATAMIENTO DE NARCOLEPSIA (Divisional 2021-0183)
MX2017013819A (es) Metodos para la reduccion de grasa.
MX2022002245A (es) Compuesto y metodos para tratar enfermedades relacionadas con oxalato.
BR112022003639A2 (pt) Agente bioestimulante para tratamento de plantas e/ou de sementes de plantas
WO2020016655A3 (en) Treatment of neuropathy with dna constructs expressing igf-1 isoforms
EA201790382A1 (ru) Способы лечения периимплантита
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
EP3632450A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE CAUSING FOOT PAIN CONSISTING OF BOTULIC TOXIN AND HYALURONIC ACID AND METHOD OF TREATMENT OF FOOT PAIN USING THE SAME